Affiliation:
1. Tuberculosis Research Centre, Indian Council of Medical Research, Madras, India.
Abstract
The bactericidal actions of ofloxacin and sulbactam-ampicillin, alone and in combination with rifampin and isoniazid, on exponential-phase and stationary-phase cultures of a drug-susceptible isolate of Mycobacterium tuberculosis were studied in vitro. In exponential-phase cultures, all drugs were bactericidal, with the higher concentrations of ofloxacin (5 micrograms/ml) and sulbactam-ampicillin (15 micrograms of ampicillin per ml) being as bactericidal as 1 microgram of isoniazid per ml or 1 microgram of rifampin per ml. In two-drug combinations, both drugs increased the levels of activity of isoniazid and rifampin and were almost as bactericidal as isoniazid-rifampin; they also appeared to increase the level of activity of isoniazid-rifampin in three-drug combinations. In contrast, ofloxacin and sulbactam-ampicillin had little bactericidal activity against stationary-phase cultures and were less active than isoniazid or rifampin alone. Furthermore, in two-drug or three-drug combinations, they did not increase the level of activity of isoniazid, rifampin, or isoniazid-rifampin. These findings suggest that ofloxacin and sulbactam-ampicillin are likely to be most useful in the early stages of treatment and in preventing the emergence of resistance to other drugs but are unlikely to be effective as sterilizing drugs helping to kill persisting lesional bacilli.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference21 articles.
1. Beta-lactamase inhibitors from laboratory to clinic;Bush K.;Clin. Microbiol. Rev.,1988
2. A stationary-phase stress-response sigma factor from Mycobacterium tuberculosis;DeMaio J.;Proc. Natl. Acad. Sci. USA,1996
3. Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis;Dickinson J. M.;Am. Rev. Respir. Dis.,1981
4. In vitro activities against mycobacteria of two long acting rifamycins, FCE 22807 and CGP 40/469A (SPA-S-565);Dickinson J. M.;Tubercle,1990
5. Pharmacokinetics of sulbactam/ampicillin in humans: a review;Foulds G.;Rev. Infect. Dis.,1986
Cited by
76 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献